Ara
Toplam kayıt 5, listelenen: 1-5
Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis?
(Lippincott Williams & Wilkins, 2020)
Despite many studies, the molecular mechanisms of hepatocellular carcinoma (HCC) development remain unclear. Thyroid hormone (TH) levels may vary in many chronic diseases including cirrhosis. the aim of this study was to ...
The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates
(Nature Research, 2021)
The aim of this study was to investigate the relationship between nonalcoholic fatty liver disease (NAFLD) and pancreatic steatosis (PS) in patients with biopsy-proven NAFLD. 228 patients with biopsy-proven NAFLD patients ...
Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?
(Sage Publications Ltd, 2021)
Background Factors causing progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis (NASH) and liver cirrhosis remain relatively unknown. We aimed to evaluate the power and effectiveness of the free ...
A New Risk-Scoring System for Colorectal Cancer and Polyp Screening by Turkish Colorectal Cancer and Polyp Study Group
(Aves, 2022)
Background: Colorectal cancer is one of the most commonly diagnosed types of cancer worldwide. An early diagnosis and detection of colon cancer and polyp can reduce mortality and morbidity from colorectal cancer. Even ...
Re: A New Risk-Scoring System for Colorectal Cancer and Polyp Screening
(Aves, 2022)
[Abstract Not Available]